Dressing heart-failure patients on Savile row - tailored treatment?

被引：11

作者：

Willenheimer, R ^{[1
]}

Swedberg, K

机构：

[1] Malmo Univ Hosp, Dept Cardiol, SE-20502 Malmo, Sweden

[2] Sahlgrens Univ Hosp, Dept Med, S-41345 Gothenburg, Sweden

来源：

LANCET | 2000年 / 355卷 / 9220期

关键词：

D O I：

10.1016/S0140-6736(00)02344-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2012 / 2013

页数：2

共 11 条

[1] EFFECT OF LONG-TERM ENALAPRIL THERAPY ON NEUROHORMONES IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION [J].

BENEDICT, CR ;

FRANCIS, GS ;

SHELTON, B ;

JOHNSTONE, DE ;

KUBO, SH ;

KIRLIN, P ;

NICKLAS, J ;

LIANG, CS ;

KONSTAM, MA ;

GREENBERG, B ;

YUSUF, S .

AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (16) :1151-1157

[2] AN EFFECT MODEL FOR THE ASSESSMENT OF DRUG BENEFIT - EXAMPLE OF ANTIARRHYTHMIC DRUGS IN POSTMYOCARDIAL INFARCTION PATIENTS [J].

BOISSEL, JP ;

COLLET, JP ;

LIEVRE, M ;

GIRARD, P .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 22 (03) :356-363

[3] THE CLINICAL COURSE OF HEART-FAILURE AND ITS MODIFICATION BY ACE-INHIBITORS - INSIGHTS FROM RECENT CLINICAL-TRIALS [J].

CLELAND, JGF .

EUROPEAN HEART JOURNAL, 1994, 15 (01) :125-130

[4]

Hjalmarson Å, 1999, LANCET, V353, P2001

[5]

Lechat P, 1999, LANCET, V353, P9

[6] Is there a role for renin profiling in selecting chronic heart failure patients for ACE inhibitor treatment? [J].

Lim, PO ;

MacFadyen, RJ ;

Struthers, AD .

HEART, 2000, 83 (03) :257-261

[7] The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J].

Pitt, B ;

Zannad, F ;

Remme, WJ ;

Cody, R ;

Castaigne, A ;

Perez, A ;

Palensky, J ;

Wittes, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) :709-717

[8] AN INSERTION DELETION POLYMORPHISM IN THE ANGIOTENSIN I-CONVERTING ENZYME GENE ACCOUNTING FOR HALF THE VARIANCE OF SERUM ENZYME LEVELS [J].

RIGAT, B ;

HUBERT, C ;

ALHENCGELAS, F ;

CAMBIEN, F ;

CORVOL, P ;

SOUBRIER, F .

JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (04) :1343-1346

[9] Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure [J].

Roig, E ;

Perez-Villa, F ;

Morales, M ;

Jiménez, W ;

Orús, J ;

Heras, M ;

Sanz, G .

EUROPEAN HEART JOURNAL, 2000, 21 (01) :53-57

[10] Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations [J].

Troughton, RW ;

Frampton, CM ;

Yandle, TG ;

Espiner, EA ;

Nicholls, MG ;

Richards, AM .

LANCET, 2000, 355 (9210) :1126-1130

← 1 2 →